Past event

Members

Anti-Microbial Resistance: A Global Health Security Threat

Chatham House, London

Event documents

Transcript
pdf | 128.76 KB
Transcript Q&A
pdf | 118.37 KB

Participants

Professor Dame Sally Davies, Chief Medical Officer for England, Department of Health, UK

Professor Kevin Outterson, Associate Fellow, Centre on Global Health Security, Chatham House; Professor of Law, Boston University

Dame Sally Davies, Chief Medical Officer & Chief Scientific Adviser, Department of Health, UK - See more at: http://www.chathamhouse.org/events/view/197651#sthash.D8ZpDc4V.dpuf
Dame Sally Davies, Chief Medical Officer & Chief Scientific Adviser, Department of Health, UK - See more at: http://www.chathamhouse.org/events/view/197651#sthash.D8ZpDc4V.dpuf
Dame Sally Davies, Chief Medical Officer & Chief Scientific Adviser, Department of Health, UK - See more at: http://www.chathamhouse.org/events/view/197651#sthash.D8ZpDc4V.dpuf
Dame Sally Davies, Chief Medical Officer & Chief Scientific Adviser, Department of Health, UK - See more at: http://www.chathamhouse.org/events/view/197651#sthash.D8ZpDc4V.dpuf

Dr Manica Balasegaram, Executive Director, Access Campaign, Médecins Sans Frontières

Dr Nick Cammack, Senior Vice-President and Head, Medicines Development for Diseases of the Developing World, GSK

Chair: Professor Mike Turner, Head of Infection and Immunobiology, Wellcome Trust

Associate Fellow, Centre on Global Health Security

Overview

The panel will examine the problem of bacteria becoming resistant to antibiotics and the threat that this poses to global health security. The speakers will consider what actions could be taken by governments, health practitioners and the pharmaceutical sector to restrict the spread of resistant infections. The panellists will also reflect on how new economic and business models could help to tackle anti-microbial resistance by encouraging the appropriate use of antibiotics and incentivising innovation in drug development.